Objectives The aim of this research was to review the literature on Alzheimer's disease (AD)
with a focus on polyphenolics as antioxidant therapeutics. Design This review included a …

It is estimated that the prevalence rate of Alzheimer's disease (AD) will double by the year
2040. Although currently available treatments help with symptom management, they do not …

Alzheimer's disease (AD) is the most prevalent neurodegenerative disease and most
common cause of dementia. However, there is no known way to halt or cure the …

Oxidative stress has been strongly implicated in the pathophysiology of neurodegenerative
disorders such as Alzheimer's disease (AD). In recent years, antioxidants–especially those …

Various neurodegenerative disorders and syndromes are associated with oxidative stress.
The deleterious consequences of excessive oxidations and the pathophysiological role of …

Aging is the major risk factor for neurodegenerative diseases such as Alzheimer's and
Parkinson's diseases. A large body of evidence indicates that oxidative stress is involved in …

Cells generate unpaired electrons, typically via oxygen-or nitrogen-based by-products
during normal cellular respiration and under stressed situations. These pro-oxidant …

Neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease and
Huntington's disease, present a major health issue and financial burden for health care …

Alzheimer's disease (AD) is a severe chronic neurodegenerative disorder of the brain
characterised by progressive impairment in memory and cognition. In the past years an …

Neurodegenerative diseases affect not only the life quality of aging populations, but also
their life spans. All forms of neurodegenerative diseases have a massive impact on the …